Corium
John Neeley has extensive work experience in the pharmaceutical industry. John started their career at Shire Pharmaceuticals in 2001, where they held the role of Senior Vice President, Market Access for over 18 years. In 2019, they joined Corium, Inc. as their Chief Commercial Officer (CCO).
John Neeley's education history includes obtaining a BS degree in Business Administration from Palm Beach Atlantic University. Additionally, they pursued an MBA from Florida Atlantic University. However, specific start and end dates for their education are not provided.
Corium
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers. Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.